AI in Clinical Trials Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

AI in Clinical Trials Market is Segmented By Offering (Software, Services), By Technology (Machine learning, Deep learning, Supervised), By Application (Cardiovascular, Metabolic, Oncology, Infectious diseases, Others), By End user (Pharma, Biotech, CROs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Competitive overview of AI in Clinical Trials Market

Zu den wichtigsten Akteuren des Global AI in Clinical Trials Market gehören Capricor Therapeutics, Codiak Biosciences, OncoTherapy Science, Bio-Techne, NanoFCM Inc., System Biosciences, LLC, AcouSort AB, Aethlon Medical, Inc., Everzom, Kimera Labs, ExoCoBio, MD Healthcare, Thermo Fisher Scientific Zhejiang, Syn University, California, University.

AI in Clinical Trials Market Leaders

  • Aegle Therapeuten
  • Coya Therapeuten
  • Evox Therapeutics
  • Nano 24
  • ReNeuron
*Disclaimer: Major players are listed in no particular order.

AI in Clinical Trials Market - Competitive Rivalry, 2023

Market Concentration Graph

AI in Clinical Trials Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

AI in Clinical Trials Market Report Snapshots

Buy Now